OTC Drug Claim Disputes In Court: P&G’S Lafley Says Take It Outside
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble is working to shift ad claims disputes out of the courts and into resolution processes such as the Council for Better Business Bureaus' National Advertising Division
You may also be interested in...
NAD Weight-Loss Claims Bulk Up In 2004; Whitening Cases Lose Luster
Nearly half of the National Advertising Division cases involving the OTC drug, dietary supplement and oral care markets thus far in 2004 were initiated by the watchdog group, and not brought forward by a competing company
Prilosec OTC Claims Found False; P&G Appeals Federal Court Ruling
Procter & Gamble says the impact of a Sept. 19 court-ordered preliminary injunction against the use of its "one pill, 24 hours, zero heartburn" claim for Prilosec OTC will be "trivial" and immaterial to the product launch
J&J/Merck Bolsters Heartburn Lineup With Maximum Strength Pepcid AC
New heartburn prevention/relief product Maximum Strength Pepcid AC will hit shelves Oct. 17, following FDA approval of the new dosage Sept. 24, according to Johnson & Johnson/Merck